Autori: Bila Jelena S
| Naslov | Prognostic impact of response-adjusted ISS score in Multiple Myeloma (Meeting Abstract) |
| Autori | Mitrovic Marko Bukumiric Zoran M Sretenovic Aleksandra M Miketic Ivana Bila Jelena S |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2021), vol. 21 br. , Suppl. 2, str. S127-S127 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Ultra-high-risk prognostic significance of double and triple hit myeloma (Meeting Abstract) |
| Autori | Bila Jelena S Mitrovic Marko Bukumiric Zoran M Jovanovic Jelica V Dencic-Fekete Marija Sretenovic Aleksandra M Jelicic Jelena J Peric Teodora Mihaljevic Biljana S Antic Darko A |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2021), vol. 21 br. , Suppl. 2, str. S123-S124 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO. (Meeting Abstract) |
| Autori | Terpos Evangelos ... Bila Jelena S ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | Janssen Research & Development, LLC Other Foundation |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | The implication and consequence of CD34+cell/subset quantity/ratio on the clinical outcome of hematologic malignancies treated by autologous stem cell transplants (Meeting Abstract) |
| Autori | Todorovic Milena R Pavlovic Mirjana A Bila Jelena S Balint Bela J |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2021), vol. 96 br. , Suppl. 1, str. S29-S29 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases (Article) |
| Autori | Gerhardt Kristin ... Sretenovic Aleksandra M ... Todorovic Milena R Bila Jelena S ... Vucinic Vladan |
| Info | FRONTIERS IN ONCOLOGY, (2021), vol. 11 br. , str. - |
| Projekat | German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group (Review) |
| Autori | Bila Jelena S Katodritou Eirini Guenova Margarita Basic-Kinda Sandra Coriu Daniel Dapcevic Milena Ibricevic-Balic Lejla Ivanaj Arben Karanfilski Oliver Zver Samo Beksac Meral Terpos Evangelos Dimopoulos Meletios Athanassios |
| Info | JOURNAL OF CLINICAL MEDICINE, (2021), vol. 10 br. 17, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial (Article) |
| Autori | Dimopoulos Meletios Athanasios ... Bila Jelena S ... (broj koautora 23) |
| Info | LANCET ONCOLOGY, (2021), vol. 22 br. 6, str. 801-812 |
| Projekat | European Myeloma Network; Janssen Research and Development |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome (vol 105, pg 201, 2020) (Correction) |
| Autori | Beksac Meral Seval Guldane Cengiz Kanellias Nicholas Coriu Daniel Rosinol Laura Ozet Gulsum Goranova-Marinova Vesselina Unal Ali Bila Jelena S Ozsan Hayri Ivanaj Arben Ibricevic-Balic Lejla Kastritis Efstathios Blade Joan Dimopoulos Meletios Athanasios |
| Info | HAEMATOLOGICA, (2021), vol. 106 br. 4, str. 1228-1228 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome (Article) |
| Autori | Beksac Meral Seval Guldane Cengiz Kanellias Nicholas Coriu Daniel Rosinol Laura Ozet Gulsum Goranova-Marinova Vesselina Unal Ali Bila Jelena S Ozsan Hayri Ivanaj Arben Ibricevic-Balic Lejla Kastritis Efstathios Blade Joan Dimopoulos Meletios Athanasios |
| Info | HAEMATOLOGICA, (2020), vol. 105 br. 1, str. 201-208 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial (Article) |
| Autori | Grosicki Sebastian ... Bila Jelena S ... (broj koautora 58) |
| Info | LANCET, (2020), vol. 396 br. 10262, str. 1563-1573 |
| Projekat | Karyopharm Therapeutics |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
